Clinical stage biotech Affimed N.V. AFMD, -0.60% said Wednesday it is terminating its phase I program for AFM11 to focus on its innate immunity portfolio. The company had put two clinical trials of the cancer treatment on hold back in October after one patient died and two others experienced life-threatening events in the high-dose group. The trials were testing the drug in patients with types of non-Hodgkin lymphoma and acute lymphoblastic leukemia.
Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Here's how much a $1,000 investment in Walmart 10 years ago would be worth nowHere's how much a $1,000 investment in Walmart 10 years ago would be worth now (via CNBCMakeIt) MakeIt How much in food stamps have WALMART employees used over the last 10yrs? Please calculate how much the US govt subsidizes WALMART & the Walton family revenues through US food stamps? MakeIt For those not wanting to watch the video.....it would be worth $2700 MakeIt Your soul.
Source: CNBC - 🏆 12. / 72 Read more »
10 Small Business Apps, Services And Tech Platforms Every Entrepreneur Should Know AboutThere are a few apps, services and technologies – about ten categories in all – that are critical for small businesses in 2019. Here they are. pretty good article.....thx Good article but some popular SME-focused apps like WaveHQ , Box , mondaydotcom , HubSpot and Calendly are missing.
Source: Forbes - 🏆 394. / 53 Read more »